• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献>>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

腹主动脉瘤腔内隔绝术中Ⅰ型内漏的纤维蛋白胶栓塞治疗

Fibrin glue embolization treating intra-operative type Ⅰ endoleak of endovascular repair of abdominal aortic aneurysm: long-term result

摘要目的 总结单中心应用纤维蛋白胶栓塞治疗腹主动脉瘤腔内隔绝术中Ⅰ型内漏的经验,研究其可行性及长期有效性.方法 2002年8月至2010年6月953例接受腹主动脉瘤腔内隔绝术的患者中,51例(5.4%)使用纤维蛋白胶栓塞术治疗术中Ⅰ型内漏.其中男性45例,女性6例,年龄49~88岁,平均年龄(72±8)岁.在栓塞术前后监测瘤腔内压力,在术后3、6和12个月及此后每年采用CT血管造影对患者进行随访.结果 经过栓塞治疗之后,50例(98.0%)Ⅰ型内漏消失,瘤腔内收缩压、舒张压、平均压、脉压差和平均压力指数均有明显降低.围手术期3例死亡(5.9%),其中1例高龄患者是由于Ⅰ型内漏无法消除,转开放手术后死于多器官功能衰竭;另2例死因与主动脉疾病无关.48例获得长期随访,中位随访时间45个月,腹主动脉瘤最大径从术前的(62±15)mm减至(49±10)mm(P =0.000).随访过程中3例患者死亡,其中1例死于瘤体持续增大压迫肾动脉造成的肾功能衰竭,另2例死因与主动脉无关;这3例患者随访期CT血管造影均未发现内漏.结论 纤维蛋白胶栓塞能有效治疗腹主动脉瘤腔内隔绝术中的Ⅰ型内漏,未见与栓塞治疗相关的并发症.在栓塞术前阻断内漏入口近端血流能增强该操作的安全性和有效性.

更多

abstractsObjective To analyze the long-term results of fibrin glue embolization to eliminate type Ⅰ endoleaks after endovascular aneurysm repair (EVAR),and to assess the feasibility and durability of this technique.Methods From August 2002 to June 2010,among the 953 EVAR patients,51 ( 5.4% )patients underwent intraoperative transcatheter fibrin glue sac embolization to resolve type Ⅰ endoleak persisting after initial intraoperative maneuvers to close the leak or in necks too short or angulated for cuff placement.Computed tomographic angiography was performed to assess the outcome after 3,6,and 12 months and annually thereafter.A retrospective study was conducted,and characteristics of the patients,intra-sac pressure,hospital course,and long-term outcomes were recorded. Results Among the 51 patients,19 (37.3% ) patients had proximal necks long <10mm,and 6 ( 11.8% ) patients had proximal neck angulation>60°; 22 patients (3 additional iliac extension,14 cuffs,and/or 8 stents) had been placed with additional devices.After fibrin glue injection,50 (98.0%) of the 51 endoleaks were successfully resolved,and intra-sac pressure (including systolic,diastolic,mean pressures,pulse pressure,and the mean pressure indexes ) decreased significantly in these cases.The patient who failed embolotherapy was converted to open surgery (2.0%) ; he died 2 months later from multiorgan failure.And other two (4.8%) patients died in the peri-operative period from myocardial infarction.The median of follow-up of 48 patients was 45 months (range 4-106 months).The mean maximal aneurysm diameter fell from the baseline (61.5±15.2)mm to (48.8 ± 10.1 ) mm (P=0.000).Three (6.2% ) patients died in the follow-up duration (1 aneurysm-related,died of renal failure which was caused by the compromised renal artery).Cumulative survival was 97.9% at 1 year,94.5% at 3 years,and 90.8% at 4 years.No recurrent type Ⅰ endoleak or glue-related complications were observed in follow-up.Conclusions Fibrin glue embolization to eliminate type Ⅰ endoleak after EVAR has yielded promising results in this study,and it can effectively and durably resolve the type Ⅰ endoleaks.Balloon occlusion of the inflow of the endoleak must be done during glue injection,to enhance the safety and facilitate formation of a structured fibrin clot.

More
广告
分类号 R6
栏目名称 腹主动脉瘤腔内治疗
DOI 10.3760/cma.j.issn.0529-5815.2011.10.006
发布时间 2012-01-12
基金项目
国家自然科学基金 上海市科技启明星计划资助项目 上海市浦江人才计划资助项目
  • 浏览620
  • 下载68
中华外科杂志

中华外科杂志

2011年49卷10期

883-887页

MEDLINEISTICPKUCSCDCA

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

扩展文献

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷